ACOR - Acorda up 21% after Q3 beat November, 05 2019 01:38 PM Acorda Therapeutics Inc. Acorda Therapeutics (ACOR +21%) is up on triple normal volume in response to its Q3 results released after the close yesterday.More news on: Acorda Therapeutics, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more ...